NotebookLM source pack · notebookLM/nlm-001

The First Letter

Education, not medical advice. Drafts and study material from an independent research library. Citations on this page were checked on Oct 13, 2026; claims in the body text and organizational sources are still under review. What was checked.

The Psychedelic Prophets · Episode 1

The First Letter

~25 minutes
PASTE THIS AS YOUR NOTEBOOKLM SOURCE DOCUMENT. Episode 1 of "The Psychedelic Prophets", the podcast series on the Huxley-Osmond correspondence. The episode covers: who Humphry Osmond was when Huxley first contacted him, the May 1953 mescaline session in Hollywood Hills, and what the first letter Huxley wrote reveals about the next ten years of correspondence. TONE: Informed and serious but not academic, think long-form journalism. The audience knows what psychedelics are and is interested in the history.
Full source material
SOURCE 1, The Hollywood Hills session (The Doors of Perception, Huxley, 1954): Huxley describes seeing a vase of flowers: "I was seeing what Adam had seen on the morning of his creation, the miracle, moment by moment, of naked existence." He describes going into the garden: "…a Last Judgment which, after a long time and with considerable difficulty, I recognized as a chair." SOURCE 2, On the coining of "psychedelic" (Marlan, Beyond Cannabis, 2019): "The term 'psychedelic' was coined by psychiatric researcher Humphry Osmond. Osmond combined the Greek words psyche ('mind' or 'soul') with delein ('to make manifest') to create a new word meaning 'mind manifesting.' Osmond's aim was to describe a class of substances that catalyze the emergence into conscious awareness of previously unconscious or repressed cognitions, perceptions, and emotions." SOURCE 3, On Osmond's Saskatchewan work (Cambridge HPS dissertation, 2007): "Humphrey Osmond and John Smythies studied mescaline in London and concluded that the outward symptoms of mescaline intoxication were similar to those of schizophrenia. In 1952, Osmond pointed out the structural similarity between mescaline and adrenaline and hypothesised that schizophrenia might have a biochemical basis. Osmond moved to Saskatchewan in Canada to continue his investigations and met Abram Hoffer, through their collaboration they realised that psychedelic drugs had great medical potential. After experimenting with LSD they noticed that the drug often provided patients with personal insights and clear self-reflection and, by 1953, they theorised that it could be used to treat chronic alcoholism." SOURCE 4, The naming competition: Huxley's losing verse: "To make this trivial world sublime, take half a gramme of phanerothyme." Osmond's winning verse: "To fathom Hell or go angelic, just take a pinch of psychedelic." The word appeared in print for the first time in the Annals of the New York Academy of Sciences in 1957. SOURCE 5, The MK-Ultra context (Drug Science, LSD History & Law, 2021): "April 13, 1953: CIA Director Allen Dulles signs the MK-Ultra authorization memorandum. The program would test LSD and other substances on unwitting subjects. May 3, 1953: Osmond administers mescaline to Huxley in Hollywood Hills. The two projects, one therapeutic, one weaponized, begin within three weeks of each other."

Focus questions

  1. 1Why did Osmond and Huxley need a new word, and what was wrong with "hallucinogen" and "psychotomimetic"?
  2. 2What was Osmond doing in Saskatchewan before he met Huxley, and why does it matter for understanding the correspondence?
  3. 3The May 1953 session produced both The Doors of Perception (the book Huxley published) and the first letters to Osmond (what he actually wrote immediately afterward). Why might those two accounts be different?
  4. 4Huxley's "phanerothyme" lost to Osmond's "psychedelic." What does each word imply about what the drugs are doing?
  5. 5What did the CIA launch in April 1953, three weeks before Huxley's session? How does knowing that change the story?
Suggested guests: Erika Dyck (historian of Saskatchewan LSD trials), or any current psychedelic therapy researcher who can speak to the clinical lineage from Osmond's work to contemporary protocols